Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022

SELL
$7.46 - $19.28 $611 - $1,580
-82 Reduced 12.33%
583 $6,000
Q2 2022

Jul 19, 2022

SELL
$15.06 - $30.65 $1,039 - $2,114
-69 Reduced 9.4%
665 $11,000
Q1 2022

May 03, 2022

SELL
$23.26 - $42.41 $3,233 - $5,894
-139 Reduced 15.92%
734 $21,000
Q4 2021

Feb 07, 2022

SELL
$37.54 - $57.51 $46,699 - $71,542
-1,244 Reduced 58.76%
873 $37,000
Q3 2021

Oct 25, 2021

SELL
$45.91 - $59.67 $48,297 - $62,772
-1,052 Reduced 33.2%
2,117 $105,000
Q2 2021

Jul 26, 2021

SELL
$43.3 - $67.17 $137,910 - $213,936
-3,185 Reduced 50.13%
3,169 $186,000
Q1 2021

Apr 27, 2021

BUY
$44.11 - $90.64 $280,274 - $575,926
6,354 New
6,354 $806,000

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $436M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.